Drug Name Hydroxychloroquine المجموعة الدوائية Immunosuppressant نوع وسيلة تقليل المخاطر رسالة سلامة دوائية Specialty (Theraputic area) Infectious disease المخاطر SFDA Recommendations for Healthcare Professionals Regarding The Unapproved Use of Hydroxychloroquine and Chloroquine in Treatment of COVID-19 Hydroxychloroquine and Chloroquine Alone and in Combination with Azithromycin and Potential Increased Risk of Heart Rhythm Problems safety communication